Papers And Originals

Long-term Treatment of Galactorrhoea and Hypogonadism with Bromocriptine

Br Med J 1974; 2 doi: https://doi.org/10.1136/bmj.2.5916.419 (Published 25 May 1974) Cite this as: Br Med J 1974;2:419
  1. M. O. Thorner,
  2. A. S. McNeilly,
  3. C. Hagan,
  4. G. M. Besser

    Abstract

    Seventeen women and four men with galactorrhoea and associated hypogonadism have been treated with bromocriptine for 2 to 28 months. In 18 patients the gonadal status became normal as the galactorrhoea improved. The gonadally unresponsive patients had either pituitary tumours or premature menopause. Prolactin levels fell with treatment; withdrawal of the drug was associated with an increase in serum prolactin and a recurrence of the galactorrhoea and hypogonadism. Two patients tried to become pregnant on treatment and both succeeded. Raised prolactin levels appear to block the actions of the gonadotrophins at a gonadal level rather than prevent their synthesis or release; lowering prolactin secretion with bromocriptine allows resumption of normal gonadal function. Bromocriptine appears to be the treatment of choice for inappropriate lactation in association with hypogonadism on a long-term basis.